Formoterol
Top View
- CDR Pharmacoeconomic Review Report for Trelegy Ellipta
- A Study with Cumulative Doses of Formoterol and Salbutamol in Children with Asthma
- Long-Acting Beta-Agonist
- Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol
- Safety of Formoterol by Turbuhaler® As Reliever Medication Compared With
- Attachment: Product Information: Indacaterol Maleate/ Glycopyrronium Bromide
- Efficacy of a New Once-Daily Long-Acting Inhaled B2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD
- Chronic Obstructive Pulmonary Disease: Indacaterol/Glycopyrronium (Ultibro Breezhaler)
- TRELEGY ELLIPTA (Fluticasone Furoate, Umeclidinium, and Vilanterol Changes Occur, Consider Appropriate Therapy
- Formoterol and Salbutamolinhibit Bradykinin- and Histamine-Induced
- Duaklir Genuair INN-Aclidinium Bromide/Formoterol Fumarate
- Revised Clinical Study Protocol Drug Substance Budesonide/Formoterol Study Code D589SC00003 Edition Number 4 Date 12 October 2016
- Formoterol Fumarate Dihydrate
- Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease
- Product Information
- Trelegy Ellipta (Fluticasone Furoate/Umeclidinium/Vilanterol)
- Anticachectic Effects of Formoterol: a Drug for Potential Treatment of Muscle Wasting
- The Musclehypertrophic Effect of Clenbuterol Is Additive to The